Clinical Trial Update: To Demonstrate the Relative Bioavailability of Fluoxetine Hydrochloride Capsules, 40 mg [Phase 1]

View source ↗

Summary

Phase 1 study completed to compare the relative bioavailability of fluoxetine hydrochloride 40 mg capsules.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Fluoxetine hydrochloride capsules 40 mg (fluoxetine hydrochloride)

Snippet

Sponsor: Sandoz | Conditions: Depression | Phase 1 | Status: COMPLETED